Title: Health, Human Services, and Elderly Affairs (2/23/21)
URL: None
Upload Date: 2021-02-23
Video ID: MjIfdch42q0

**Comprehensive Summary of NH House of Representatives Health, Human Services, and Elderly Affairs Committee Meeting (2/23/21)**

The New Hampshire House of Representatives Health, Human Services, and Elderly Affairs Committee convened on February 23, 2021, to discuss several key bills related to health, human services, and elderly affairs. The meeting, conducted electronically due to the COVID-19 state of emergency, focused on therapeutic cannabis, patient rights, bodily integrity, vaccine registries, and other healthcare-related issues. Below is a cohesive summary of the key discussions and outcomes from the meeting:

---

### **Therapeutic Cannabis Program Expansion**
Several bills aimed at expanding New Hampshire’s therapeutic cannabis program were discussed:

1. **House Bill 89 (HB 89)**:
   - **Purpose**: Adds **autism spectrum disorder (ASD)** and **moderate to severe insomnia** as qualifying conditions for therapeutic cannabis use.
   - **Amendment**: Representative Kenner proposed an amendment to include ASD, with safeguards for minors requiring specialist consultation.
   - **Supporting Testimony**: Medical professionals and advocates highlighted the benefits of cannabis for sleep and ASD management, sharing anecdotal evidence and scientific support.
   - **Outcome**: The committee passed the amendment and moved the bill forward with broad support.

2. **House Bill 90 (HB 90)**:
   - **Purpose**: Proposed allowing outsourced CBD isolates in therapeutic cannabis products.
   - **Outcome**: The committee moved to **Inexpedient to Legislate (ITL)** due to market oversupply and quality concerns, supported by testimony from industry representatives and the Department of Health and Human Services (DHHS).

3. **House Bill 599 (HB 599)**:
   - **Purpose**: Proposed changes to the Therapeutic Cannabis Medical Oversight Board (TCMOB).
   - **Outcome**: The committee moved to ITL, citing redundant and impractical requirements, with testimony from the TCMOB chair and DHHS.

4. **House Bill 605 (HB 605)**:
   - **Purpose**: Consolidated several therapeutic cannabis proposals, including home cultivation, expanded qualifying conditions (e.g., opioid use disorder and insomnia), and reciprocity for out-of-state patients.
   - **Key Discussions**: Focused on the controversial addition of opioid use disorder (OUD) and the need to streamline redundant provisions.
   - **Outcome**: The committee delayed further action pending amendments to refine the bill’s focus.

---

### **Patient Rights and Transparency**
1. **House Bill 146 (HB 146)**:
   - **Purpose**: Requires healthcare providers to furnish a list of ingredients in injectable medications upon patient request.
   - **Debate**: Concerns were raised about practicality in emergency settings and potential conflicts with federal FDA regulations.
   - **Outcome**: The bill passed with unanimous support, but further amendments may be needed to address implementation challenges.

2. **House Bill 220 (HB 220)**:
   - **Purpose**: Affirms the right to bodily integrity, allowing individuals to refuse unwanted medical interventions, including immunizations.
   - **Amendment 0334H**: Added exceptions for involuntary emergency admissions, school vaccination requirements, guardianship decisions, and public health orders, aligning with federal EEOC standards.
   - **Debate**: Focused on balancing individual rights with public health needs, particularly in high-risk settings like nursing homes and schools.
   - **Outcome**: The amendment passed unanimously, and the bill, as amended, was supported by many representatives.

---

### **Vaccine Registry and Public Health**
1. **House Bill 221 (HB 221)**:
   - **Purpose**: Proposes making the state vaccine registry an **opt-in program** rather than opt-out.
   - **Debate**: Supporters emphasized individual privacy rights, while opponents argued that an **opt-out system** is critical for effective public health data collection and disease management.
   - **Outcome**: The bill failed after a motion to declare it **inexpedient to legislate** passed, with concerns about compromising public health efforts.

2. **House Bill 143 (HB 143)**:
   - **Purpose**: Amended to exempt hospice patients and compounded medications from an electronic prescription drug program.
   - **Outcome**: Passed with broad support.

---

### **Key Themes and Outcomes**
- **Therapeutic Cannabis**: The committee demonstrated a commitment to expanding access to therapeutic cannabis while maintaining high standards for patient safety and program integrity.
- **Patient Rights**: Bills like HB 146 and HB 220 highlighted the importance of transparency and individual autonomy in healthcare decisions, though concerns about practicality and public health implications were noted.
- **Public Health vs. Privacy**: The debate over HB 221 underscored the tension between individual privacy rights and the need for robust public health infrastructure, particularly in the context of vaccine registries.
- **Collaborative Process**: The committee’s willingness to consider amendments and testimony from stakeholders reflected a balanced approach to addressing complex healthcare issues.

---

### **Conclusion**
The meeting showcased the committee’s efforts to address a wide range of healthcare issues, from therapeutic cannabis expansion to patient rights and public health policy. While some bills passed with broad support, others faced significant debate or were deemed inexpedient to legislate. The discussions highlighted the importance of balancing individual rights with collective welfare, ensuring transparency, and maintaining high standards in healthcare legislation. The committee’s commitment to careful deliberation and stakeholder input will guide further action on these bills.